Reduced expression of syndecan-1 in human hepatocellular carcinoma with high metastatic potential

International Journal of Cancer

Volumn 74, Issue 5, 1997, Pages 482-491

  Matsumoto, Akinori ^a   Ono, Minoru ^a   Fujimoto, Yoshinori ^a   Gallo, Richard L ^b   Bernfield, Merton ^b   Kohgo, Yutaka ^a  

^a ASAHIKAWA MEDICAL COLLEGE   (Japan)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SYNDECAN; SYNDECAN 1; UNCLASSIFIED DRUG;

ARTICLE; BILE DUCT; HEPATITIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CARCINOMA; LIVER CELL; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; METASTASIS; METASTASIS POTENTIAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR DIFFERENTIATION;

EID: 0030720094     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1097-0215(19971021)74:5<482::aid-ijc2>3.0.co;2-%23     Document Type: Article

References (19)

1. BERNFIELD, M., KOKENYESI, R., KATO, M., HINKES, M.T., SPRING, J., GALLO, R.L. and LOSE, E.J., Biology of the syndecans: a family of transmembrane heparan-sulfate proteoglycans. Ann. Rev. Cell. Biol., 8, 365-393 (1992).
2. CHOMCZYNSKI, P. and SACCHI, N., Single-step method of RNA isolation by acid-guanidinium-thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162, 156-159 (1987).
3. DOI, I., NAMBA, M. and SATO, J., Establishment and some biological characteristics of human hepatoma cell lines. Jap. J. Cancer Res., 66, 385-392 (1975).
4. GALLO, R., KIM, C. KOKENYESI, R., ADZICK, S. and BERNFIELD, M., Syndecan-1 and -4 are induced during wound repair of neonatal hut not fetal skin. J. invest. Dermatol., 107, 670-683 (1996).
5. GALLO, R.L., ONO, M., POVSIC, T., PAGE, C., ERIKSSON, E., KLAGSBRUN, M. and BERNFIELD, M., Syndecans, cell-surface heparan-sulfate proteoglycans, are induced by a proline-rich anti-microbial peptide from wounds. Proc. nat. Acad. Sci. (Wash.), 91, 11035-11039 (1994).
6. HAYASHI, K., HAYASHI, M., JALKANEN, M., FIRESTONE, J.H., TRESTAD, R.L., and BERNFIELD, M., Immunocytochemistry of cell-surface heparan-sulfate proteoglycan in mouse tissues. A light- and electron-microscopic study. J. Histochem. Cytochem., 35, 1079-1088 (1987).
7. HUH, N. and UTAKOJI, T., Production of HBs-antigen by two new human hepatoma cell lines and its enhancement by dexamethasone. Jap. J. Cancer Res. 72, 178-179 (1981).
8. INKI, P., JOENSUU, H., GRENMAN, R., KLEMI, P. and JALKANEN, M., Association between syndecan-1 expression and clinical outcome in squamous-cell carcinoma of the head and neck. Brit. J. Cancer, 70, 319-323 (1994a).
9. INKI, P., KUJARI, H. and JALKANEN, M., Syndecan in carcinomas produced from transformed epithelial cells in nude mice. Lab. Invest., 66, 314-323 (1992).
10. INKI, P., STENBACK, F., GRENMAN, S., and JALKANEN, M., Immunohistochemical localization of syndecan-1 in normal and pathological human uterine cervix. J. Pathol., 172, 349-355 (1994).
11. KATO, M., SAUNDERS, S., NGUYEN, H. and BERNFIELD, M., Loss of cell-surface syndecan-1 causes epithelia to transform into anchorage-independent mesenchyme-like cells. Mol. cell. Biol., 6, 559-576 (1995).
12. KIRJAVAINEN, J., LEPPA, S., HYNES, N.E. and JALKANEN, M., Translational suppression of syndecan-1 expression in Ha-ras transformed mouse mammary epithelial cells. Mol. cell. Biol., 4, 849-858 (1993).
13. KODA, J.E., RAPRAEGER, A. and BERNFIELD, M., Heparan-sulfate proteoglycans from mouse mammary epithelial cells. Cell-surface proteoglycans as a receptor for interstitial collagens. J. biol. Chem., 260, 8157-8162 (1985).
14. LEPPA, S., MALI, M., MIETTINEN, M. and JALKANEN, M., Syndecan expression regulates cell morphology and growth of mouse mammary epithelial tumor cells. Proc. nat. Acad. Sci. (Wash.), 89, 932-936 (1992).
15. LIEBERSBACH, B.F. and SANDERSON, R.D., Expression of syndecan-1 inhibits cell invasion into type-l collagen. J. biol. Chem., 269, 20013-20019 (1994).
16. LIVER CANCER STUDY GROUP OF JAPAN. Histological classification of primary liver cancer. In: K. Sugawara (ed.), The general rules of the clinical and pathological study of primary liver cancer. Vol. 3, pp. 34-36. Kanahara shuppan, Tokyo (1992).
17. RAPRAEGER, A., JALKANEN, M., ENDO, E., KODA, J.E. and BERNFIELD, M., The cell-surface proteoglycan from mouse mammary epithelial cells bears chondroitin-sulfate and heparan-sulfate GAGs. J. biol. Chem., 260, 11046-11052 (1985).
18. ROSKAMS, T., MOSHAGE, H., VOS, R.D., GUIDO, D., YAP, P. and DESMET, V., Heparan-sulfate proteoglycan expression in normal human liver. Hepatology, 21, 950-958 (1995).
19. ROSKAMS, T., ROSENBAUM, J., VOS, R.D., DAVID, G. AND DESMET, V., Heparan-sulfate proteoglycan expression in chronic cholestatic human liver diseases. Hepatology, 24, 524-532 (1996).